132 related articles for article (PubMed ID: 2906458)
1. Assessment of intragastric acidity in man: modern aspects, reproducibility of intragastric pH-monitoring, and pharmacodynamic results obtained with H2-receptor antagonists.
Merki HS; Witzel L; Kaufmann D; Kempf M; Muessig V; Neumann J; Scheurle E; Roehmel J; Walt RP
Scand J Gastroenterol Suppl; 1988; 146():142-52. PubMed ID: 2906458
[TBL] [Abstract][Full Text] [Related]
2. The effects of roxatidine acetate on 24-hour intragastric acidity. Investigations in healthy volunteers and comparison with ranitidine and placebo.
Merki HS; Witzel L; Kaufmann D; Kempf M; Neumann J; Scheurle E; Röhmel J; Walt RP
Drugs; 1988; 35 Suppl 3():69-75. PubMed ID: 2905252
[TBL] [Abstract][Full Text] [Related]
3. The effects of roxatidine acetate (HOE-760) on 24-hour intragastric acidity in healthy volunteers: comparison with ranitidine and placebo.
Merki HS; Witzel L; Kaufmann D; Kempf M; Müssig V; Neumann J; Scheurle E; Röhmel J; Walt RP
Aliment Pharmacol Ther; 1988 Feb; 2(1):73-81. PubMed ID: 2908751
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of roxatidine acetate. Evidence from pharmacodynamic and clinical trials.
Merki HS; Bender W; Labs R
J Clin Gastroenterol; 1989; 11 Suppl 1():S20-3; discussion S24. PubMed ID: 2572621
[TBL] [Abstract][Full Text] [Related]
5. Effects of roxatidine acetate on 24-hour gastric acidity. Early evening versus bedtime administration in healthy subjects.
Hemery P; Congard P; Galmiche JP; Bonfils S
Drugs; 1988; 35 Suppl 3():76-81. PubMed ID: 2905253
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and pharmacodynamics of roxatidine in patients with renal insufficiency.
Gladziwa U; Wagner S; Sieberth HG; Klotz U
Br J Clin Pharmacol; 1995 Feb; 39(2):161-7. PubMed ID: 7742154
[TBL] [Abstract][Full Text] [Related]
7. Twenty-four-hour intragastric acidity following early evening or bedtime administration of roxatidine in duodenal ulcer patients.
Lazzaroni M; Sangaletti O; Bargiggia S; Bensi G; Canali A; Bianchi Porro G
Aliment Pharmacol Ther; 1996 Apr; 10(2):187-91. PubMed ID: 8730248
[TBL] [Abstract][Full Text] [Related]
8. Absence of tolerance in duodenal ulcer patients treated for 28 days with a bedtime dose of roxatidine or ranitidine.
Savarino V; Mela GS; Zentilin P; Cutela P; Vigneri S; Termini R; Di Mario F; Ferrana M; Malesci A; Belicchi M; Celle G
Fundam Clin Pharmacol; 1996; 10(3):304-8. PubMed ID: 8836705
[TBL] [Abstract][Full Text] [Related]
9. [Effects of different dosages of roxatidine on 24 hrs intragastric pH].
Kihira K; Yoshida Y; Kasano T; Hirose M; Sato K; Hashimoto M; Kimura K
Nihon Naika Gakkai Zasshi; 1989 Jul; 78(7):968-9. PubMed ID: 2571653
[No Abstract] [Full Text] [Related]
10. Effect of roxatidine acetate on daytime and night-time peptone-stimulated gastric acid secretion.
Hagenmüller F
Drugs; 1988; 35 Suppl 3():65-8. PubMed ID: 2905251
[TBL] [Abstract][Full Text] [Related]
11. The effects of low doses of ranitidine on intragastric acidity in healthy men.
Wyeth JW; Pounder RE; Sercombe JC; Snell CC
Aliment Pharmacol Ther; 1998 Mar; 12(3):255-61. PubMed ID: 9570260
[TBL] [Abstract][Full Text] [Related]
12. Effect of Wy-45,727 on 24 h intragastric acidity in twenty normal volunteers.
Merki HS; Kaufmann D; Kempf M; Mappes A; Heim J; Roehmel J; Walt RP
Br J Clin Pharmacol; 1989 Feb; 27(2):135-8. PubMed ID: 2565728
[TBL] [Abstract][Full Text] [Related]
13. Does smoking interfere with the effect of histamine H2-receptor antagonists on intragastric acidity in man?
Bauerfeind P; Cilluffo T; Fimmel CJ; Emde C; von Ritter C; Kohler W; Gugler R; Gasser T; Blum AL
Gut; 1987 May; 28(5):549-56. PubMed ID: 3596336
[TBL] [Abstract][Full Text] [Related]
14. The pharmacodynamics and pharmacokinetics of multiple doses of the new H2-receptor antagonist, roxatidine acetate, in healthy men.
Lassman HB; Ho I; Puri SK; Sabo R; Scheffler MR
Drugs; 1988; 35 Suppl 3():53-64. PubMed ID: 2905250
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics of roxatidine acetate: a review.
Dammann HG; de Looze SM; Bender W; Labs R
Scand J Gastroenterol Suppl; 1988; 146():121-34. PubMed ID: 2906456
[TBL] [Abstract][Full Text] [Related]
16. Continuous intragastric pH monitoring: a real progress in the assessment of antisecretory drugs.
Savarino V
Ital J Gastroenterol; 1990; 22 Suppl 2():20-3. PubMed ID: 1983412
[TBL] [Abstract][Full Text] [Related]
17. Roxatidine in duodenal ulcer.
Habibullah CM; Habeeb MA; Singh SP
J Postgrad Med; 1995; 41(3):64-5. PubMed ID: 10707717
[TBL] [Abstract][Full Text] [Related]
18. Single dose treatment with H2 receptor antagonists: is bedtime administration too late?
Merki H; Witzel L; Harre K; Scheurle E; Neumann J; Röhmel J
Gut; 1987 Apr; 28(4):451-4. PubMed ID: 3583073
[TBL] [Abstract][Full Text] [Related]
19. Is the time of dosing of a potent long-acting H2-receptor antagonist critical? Twenty-four-hour pH measurements with SKF-94482.
Wilder-Smith CH; Merki HS
Scand J Gastroenterol; 1991 May; 26(5):501-7. PubMed ID: 1678550
[TBL] [Abstract][Full Text] [Related]
20. Comparative pharmacology of histamine H2-receptor antagonists.
Sewing KF; Beil W; Hannemann H
Drugs; 1988; 35 Suppl 3():25-9. PubMed ID: 2905246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]